TrialCurrent neuropharmacology2022

Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial.

Arianna Di Stadio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.